Cancer Prevention and Research Institute of Texas logo
CPRIT Product Development Research

CPRIT PDR — Texas New Technologies Company

Funds Texas oncology startups in emerging technologies, including digital and life science manufacturing pathways.

OpenCancer Prevention and Research Institute of TexasUnited StatesEligible in Texas

The Cancer Prevention and Research Institute of Texas (CPRIT) operates the Texas New Technologies Company RFA as part of its Product Development Research program, which allocates approximately $70 million per fiscal year to Texas-based oncology companies. This track specifically serves oncology-enabling technologies that do not fit the Therapeutics or Device/Diagnostics RFAs — covering bioinformat

Oncology-enabling technologies — bioinformatics, AI, radionuclides, cell-based therapy manufacturing, sample quality tools, and biomanufacturing — not fitting the therapeutics or device tracks.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.4 weeks
Project durationiHow long the funded work is expected to run.36 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Royalty-back
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.50%
Funding pooliThe total budget available across all awards in this round.$70M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Last verified: 22 Jul 2026Source: cprit.texas.gov